Back to today’s briefing

Story perspectives

Today in History: Zidovudine becomes first FDA-approved HIV/AIDS treatment

3/20/2026

40 4

Summary

Story summary

On March 20, 1987, the U.S. Food and Drug Administration approved zidovudine (AZT) as the first antiretroviral treatment for HIV/AIDS. This landmark decision marked a significant advancement in managing the virus, allowing patients to suppress viral loads and improve life expectancy. Zidovudine remains a crucial component in HIV treatment regimens today.

1 of 1

Story summary

On March 20, 1987, the U.S. Food and Drug Administration approved zidovudine (AZT) as the first antiretroviral treatment for HIV/AIDS. This landmark decision marked a significant advancement in managing the virus, allowing patients to suppress viral loads and improve life expectancy. Zidovudine remains a crucial component in HIV treatment regimens today.